Article
Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma
14 Jun 2019
Abstract excerpt
Due to the poor prognosis of advanced metastatic melanoma, it is crucial to find early biomarkers that help identify which melanomas will metastasize. By comparing the gene expression data from primary and cutaneous melanoma samples from The Cancer Genome Atlas (TCGA), we identified GPC6 among a set of genes whose expression levels can distinguish between primary melanoma and regional cutaneous/subcutaneous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
